Staff Publications: September 2016

1.    Adams DL, Alpaugh RK, Tsai S, Tang CM, Stefansson S. Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining. Sci Rep. 2016;6:33488. PMID: 27647345 PMCID: PMC5028835.

2.    Allen JE, Kline CL, Prabhu VV, et al. Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget. 2016 PMID: 27602582.

3.    Atretkhany KN, Drutskaya MS, Nedospasov SA, Grivennikov SI, Kuprash DV. Chemokines, cytokines and exosomes help tumors to shape inflammatory
microenvironment. Pharmacol Ther. 2016 PMID: 27613100.

4.    Avkshtol V, Doss M, Devarajan K, et al. Using Metabolic Tumor Velocity to Preoperatively Predict the Neoadjuvant Rectal Score. Int J Radiat Oncol Biol Phys. 2016;96(2S):E206-E207. PMID: 27674061.

5.    Bass SB, Wolak C, Greener J, et al. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016;28(4):528-536. PMID: 26572215.

6.    Bassi DE, Zhang J, Renner C, Klein-Szanto AJ. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth. Mol Carcinog. 2016 PMID: 27584082.

7.    Bauman JR, Piotrowska Z, Muzikansky A, et al. End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations. J Palliat Med. 2016 PMID: 27626514.

8.    Bellacosa A, Chernoff J, Testa JR. Alfred G. Knudson (1922-2016) Obituary. Cell. 2016;166(4):785-786. WOS:000382258700001.

9.    Borghaei H, Brahmer J, Horn L, et al. P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis: Track: Immunotherapy. J Thorac Oncol. 2016;11(10S):S237-S238. PMID: 27676569.

10.    Buscariollo D, Cronin A, Bleicher RJ, et al. Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E13. PMID: 27673854.

11.    Cagney DN, Van Dijk KR, Horvath MC, et al. Cortical Structural Changes in Patients Receiving Whole-Brain Radiation Therapy (WBRT). Int J Radiat Oncol Biol Phys. 2016;96(2S):E71-E72. PMID: 27675426.

12.    Chen L, Cvetkovic D, Wang B, Gupta R, Ma CM. Management of Prostate Cancer Using Magnetic Resonance Guided Pulsed Focused Ultrasound-Mediated Targeted Chemotherapeutic Agent Delivery. Int J Radiat Oncol Biol Phys. 2016;96(2S):E260. PMID: 27674203.

13.    Chow LQ, Haddad R, Gupta S, et al. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort. J Clin Oncol. 2016 PMID: 27646946.

14.    Churilla TM, Egleston BL, Murphy CT, et al. Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast Cancer Res Treat. 2016 PMID: 27640196.

15.    Churilla TM, Handorf E, Soffietti R, et al. Does Whole-Brain Radiation Therapy for Oligometastatic Brain Metastases Translate Into a Survival Benefit for Patients With a Limited Competing Risk From Extracranial Disease? A Secondary Analysis of EORTC 22952-26001. Int J Radiat Oncol Biol Phys. 2016;96(2S):S56-S57. PMID: 27675960.

16.    Corradetti C, Jog NR, Gallucci S, Madaio M, Balachandran S, Caricchio R. Immune-Mediated Nephropathy and Systemic Autoimmunity in Mice Does Not Require Receptor Interacting Protein Kinase 3 (RIPK3). PLoS One. 2016;11(9):e0163611. PMID: 27669412.

17.    Dhawan I, Li T, Fundakowski C, et al. Is a Focally Positive Margin During Glossectomy an Indication for Adjuvant Radiation If the Margin Is Re-Resected During the Same Operation? Int J Radiat Oncol Biol Phys. 2016;96(2S):E349-E350. PMID: 27674448.

18.    Dong Y, Li T, Churilla TM, et al. Long-Term Toxicities in Survivors of Radiation Treatment for Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E394. PMID: 27674573.

19.    Dziemianowicz M, Murphy CT, Devarajan K, et al. Evaluating the Impact of Node-Specific Growth in Patients With Node-Positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E368-E369. PMID: 27674500.

20.    El-Deiry WS. p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy. Cancer Res. 2016;76(18):5189-5191. PMID: 27635040 PMCID: PMC5028108.
21.    Escalante DA, Wang H, Fundakowski CE. Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting. Cancer Biol Ther. 2016:1-8. PMID: 27636353.

22.    Fareed MM, Churilla TM, Galloway TJ. Impact of Primary Tumor-Specific Growth Rate on Treatment Failure for Non-Oropharyngeal Head and Neck Cancers. Int J Radiat Oncol Biol Phys. 2016;96(2S):E390. PMID: 27674561.

23.    Feitelson MA, Arzumanyan A, Kulathinal RJ, et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35 Suppl:S25-54. PMID: 25892662 PMCID: PMC4898971.

24.    Flynn KE, Lin L, Bruner DW, et al. Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults. J Sex Med. 2016 PMID: 27671968.

25.    Gray PN, Vuong H, Tsai P, et al. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy. Oncotarget. 2016 PMID: 27626691.

26.    Hawken SR, Krishnan NK, Ambani SN, et al. Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs). Urol Oncol. 2016 PMID: 27687544.

27.    Heckman CJ, Kloss JD, Feskanich D, Culnan E, Schernhammer ES. Associations among rotating night shift work, sleep and skin cancer in Nurses’ Health Study II participants. Occup Environ Med. 2016 PMID: 27663986.

28.    Hoffman JP, Reddy SS. Is It Time for Total Neoadjuvant Therapy for Patients With Resectable Pancreatic Adenocarcinoma? J Oncol Pract. 2016;12(9):780-781. PMID: 27621327.

29.    Horwitz SM, Zelenetz AD, Gordon LI, et al. NCCN Guidelines Insights: Non-Hodgkin’s Lymphomas, Version 3.2016. J Natl Compr Canc Netw. 2016;14(9):1067-1079. PMID: 27587620.

30.    Hu B, Arpag S, Zhang X, et al. Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP. PLoS Genet. 2016;12(9):e1006290. PMID: 27583434 PMCID: PMC5008806.

31.    Johnson SB, Soulos PR, Shafman TD, et al. Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E242. PMID: 27674157.

32.    Kachnic LA, Moughan J, Suntharalingam M, et al. Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery. Int J Radiat Oncol Biol Phys. 2016;96(2S):S31. PMID: 27675900.

33.    Kelly KR, Gabrail N, Weitman S, et al. Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal impairment. Cancer Chemother Pharmacol. 2016 PMID: 27638045.

34.    Kishan AU, Shaikh T, Wang J, et al. Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis. Int J Radiat Oncol Biol Phys. 2016;96(2S):E229. PMID: 27674120.

35.    Koutrouli N, Anagnostopoulos F, Tsikkinis A, Papastylianou D, Lepore S. Psychometric properties of the Greek version of the Social Constraints Scale in a sample of women with breast cancer. Women Health. 2016;56(4):413-427. PMID: 26496047.

36.    Kurland BF, Egleston BL. For Health-Related Quality of Life and Other Longitudinal Data, Analysis Should Distinguish Between Truncation by Death and Data Missing Because of Nonresponse. J Clin Oncol. 2016 PMID: 27601541.

37.    Lawrenson K, Kar S, McCue K, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nat Commun. 2016;7:12675. PMID: 27601076 PMCID: PMC5023955.

38.    Leachman BK, Shaikh T, Li T, Anderson PR. Association Between Body Mass Index and Treatment Outcomes in Women Undergoing Breast Conservation: An Analysis of 3850 Women. Int J Radiat Oncol Biol Phys. 2016;96(2S):E59. PMID: 27675097.

39.    Ma CM, Eldib A, Chibani O, Mora G, Li J, Chen L. Exploring the Dosimetric Advantages of Cobalt Beams for Lung Cancer Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016;96(2S):E655-E656. PMID: 27675277.

40.    Maluchenko NV, Chang HW, Kozinova MT, et al. [Inhibiting the pro-tumor and transcription factor FACT: Mechanisms]. Mol Biol (Mosk). 2016;50(4):599-610. PMID: 27668600.

41.    Maluchenko NV, Chang HW, Kozinova MT, et al. Inhibiting the pro-tumor and transcription factor FACT: Mechanisms. Molecular Biology. 2016;50(4):532-541.

42.    Merza H, Sarkar R. Solitary extraosseous plasmacytoma. Clin Case Rep. 2016;4(9):851-854. PMID: 27648261 PMCID: PMC5018587.

43.    Meyer JE, Galloway TJ, Ruth K, et al. Efficacy of Pulsed Low-Dose-Rate Reirradiation: Results From a Phase 1 Clinical Trial. Int J Radiat Oncol Biol Phys. 2016;96(2S):S147. PMID: 27675641.

44.    Meyer LA, Cronin AM, Sun CC, et al. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 PMID: 27601552.

45.    Miron B, Ristau BT, Tomaszewski JJ, et al. Biology is Destiny: A Case of Adrenocortical Carcinoma Diagnosed and Resected at Inception in a Patient Under Close Surveillance for Lung Cancer. Urol Case Rep. 2016;9:9-11. PMID: 27617213 PMCID: PMC5011172.

46.    Morgan RJ, Armstrong DK, Alvarez RD, et al. Ovarian Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network. 2016;14(9):1134-1163. WOS:000382903900009.

47.    Murphy CT, Handorf E, Sigurdson ER, et al. Assessment of National Practice Patterns of Radiation Therapy Use after Neoadjuvant Chemotherapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E51-E52. PMID: 27674882.

48.    Paly J, Shaikh T, Scott WJ, et al. Comparative Effectiveness of Standard Versus High-Dose Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):S200-S201. PMID: 27675778.

49.    Peri S, Caretti E, Tricarico R, et al. Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. Oncotarget. 2016 PMID: 27682873.

50.    Perrapato SD, Gore J, du Plessis M, et al. A Genomic Classifier Impacts Treatment Decision Making Among Patients With Biochemical Recurrence After Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study. Int J Radiat Oncol Biol Phys. 2016;96(2S):E222-E223. PMID: 27674104.

51.    Pishvaian M, Morse MA, McDevitt J, et al. Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas. Clin Colorectal Cancer. 2016 PMID: 27591895.

52.    Rahman R, Catalano PJ, Arvold ND, et al. Chemoradiation-Related Lymphopenia Is Common Among Glioblastoma Patients and Is Associated With Worse Progression-Free and Overall Survival. Int J Radiat Oncol Biol Phys. 2016;96(2S):E123. PMID: 27673836.

53.    Rall G, Knoll LJ. Development of Complex Models to Study Co- and Polymicrobial Infections and Diseases. PLoS Pathog. 2016;12(9):e1005858. PMID: 27607188 PMCID: PMC5015861.

54.    Ramos JD, Casey MF, Bamias A, et al. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy. Clin Appl Thromb Hemost. 2016 PMID: 27637910.

55.    Reese JB, Porter LS, Casale KE, et al. Adapting a couple-based intimacy enhancement intervention to breast cancer: A developmental study. Health Psychol. 2016;35(10):1085-1096. PMID: 27657981 PMCID: PMC5034713.

56.    Ristau BT, Geynisman DM. Patient-reported and Cost-effectiveness Outcomes Are Key to Determining the Optimal Therapeutic Sequence for Patients with Metastatic Renal Cell Carcinoma. Eur Urol. 2016 PMID: 27638095.

57.    Shaikh T, Churilla TM, Murphy CT, Hallman MA, Scott WJ, Meyer JE. Comparative Effectiveness of Lobectomy, Sublobar Resection, and Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Propensity-Matched Analysis. Int J Radiat Oncol Biol Phys. 2016;96(2S):E451-E452. PMID: 27674728.

58.    Shaikh T, Churilla TM, Zaorsky NG, et al. Postmastectomy Radiation Therapy in Women With ypN0-N3 Breast Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E27. PMID: 27674227.

59.    Shaikh T, Ruth K, Devarajan K, et al. Dosimetric and Clinical Predictors of Long-Term Toxicity in Patients Undergoing Hypofractionated Prostate Radiation Therapy: Results From a Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2016;96(2S):S123. PMID: 27675581.

60.    Sisti DA, Ramamurthy C. From alienism to ACOs: Integrating psychiatry, again. Psychiatric Services. 2016;67(4):372-374.

61.    Smith TM, McGovern K, Mojica A, Bhattacharya A. Hepatitis B virus immunity 15 years after vaccination: Implications for young adults. Consultant. 2016;56(9):796-798.

62.    Solomos AC, O’Regan KJ, Rall GF. CD4+ T cells require either B cells or CD8+ T cells to control spread and pathogenesis of a neurotropic infection. Virology. 2016;499:196-202. PMID: 27677156.

63.    Thomas C, Movva S. Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survival. Onco Targets Ther. 2016;9:5619-5627. PMID: 27672333 PMCID: PMC5024770.

64.    Tricarico R, Kasela M, Mareni C, et al. Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants. Hum Mutat. 2016 PMID: 27629256.

65.    Wang EH, Abouassaly R, Yu JB, et al. Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort. Int J Radiat Oncol Biol Phys. 2016;96(2S):E258. PMID: 27674195.

66.    Wang Y, Krais JJ, Bernhardy AJ, et al. RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance. J Clin Invest. 2016;126(8):3145-3157. PMID: 27454289 PMCID: PMC4966309.

67.    Yao M, Zhang Q, Woods CR, et al. Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Head and Neck Squamous Cell Carcinoma: A Pooled Analysis of NRG Oncology/RTOG 0129 and 0522. Int J Radiat Oncol Biol Phys. 2016;96(2S):S116-S117. PMID: 27675562.

68.    Yoon S, Shaikh T, Ross EA, et al. Patterns and Predictors of Failure Following Definitive Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2016;96(2S):E477-E478. PMID: 27674796.

69.    Yu J, Gong Y, Yuan L, et al. Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning. Int J Radiat Oncol Biol Phys. 2016;96(2S):E230-E231. PMID: 27674126.

70.    Zaorsky NG, Handorf E, Horwitz EM, Hallman MA, Smaldone MC. Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E280. PMID: 27674259.

71.    Zaorsky NG, Ricco A, Churilla TM, Horwitz EM, Den RB. Applying ASTRO APEx Guidelines and RO-ILS to Medical Malpractice in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2016;96(2S):E540. PMID: 27674964.

72.    Zhang Y, Xie J, Wang J, et al. Clinicopathological and Prognostic Analysis of Neuroendocrine Carcinoma of the Colorectum. Adv Clin Exp Med. 2016;25(4):719-724. PMID: 27629846.

73.    Zijoo R, von Mehren M. Efficacy of trabectedin for the treatment of liposarcoma. Expert Opin Pharmacother. 2016;17(14):1953-1962. PMID: 27615729.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s